ResMed Inc (RMD) - Total Assets
Based on the latest financial reports, ResMed Inc (RMD) holds total assets worth $8.78 Billion USD as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore ResMed Inc strategic investment ratio to see how much of total assets are deployed in long-term investments.
ResMed Inc - Total Assets Trend (1993–2025)
This chart illustrates how ResMed Inc's total assets have evolved over time, based on quarterly financial data. Check RMD asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
ResMed Inc - Asset Composition Analysis
Current Asset Composition (June 2025)
ResMed Inc's total assets of $8.78 Billion consist of 42.9% current assets and 57.1% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $1.21 Billion | 14.8% |
| Accounts Receivable | $990.67 Million | 12.1% |
| Inventory | $927.71 Million | 11.4% |
| Property, Plant & Equipment | $718.29 Million | 8.8% |
| Intangible Assets | $464.86 Million | 5.7% |
| Goodwill | $3.05 Billion | 37.3% |
Asset Composition Trend (1993–2025)
This chart illustrates how ResMed Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see ResMed Inc (RMD) market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: ResMed Inc's current assets represent 42.9% of total assets in 2025, a decrease from 86.5% in 1993.
- Cash Position: Cash and equivalents constituted 14.8% of total assets in 2025, down from 32.7% in 1993.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 42.0% of total assets, an increase from 1.0% in 1993.
- Asset Diversification: The largest asset category is goodwill at 37.3% of total assets.
ResMed Inc Competitors by Total Assets
Key competitors of ResMed Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Hubei Huaqiang High-Tech Co. Ltd. A
SHG:688151
|
China | CN¥4.77 Billion |
|
Pegavision
TW:6491
|
Taiwan | NT$16.17 Billion |
|
SWS Hemodialysis Care Co. Ltd. A
SHG:688410
|
China | CN¥2.06 Billion |
|
Caina Technology Co. Ltd.
SHE:301122
|
China | CN¥2.24 Billion |
|
IVF Hartmann Holding AG
SW:VBSN
|
Switzerland | CHF180.92 Million |
|
Dentium
KO:145720
|
Korea | ₩932.79 Billion |
|
Medeon Biodesign
TWO:6499
|
Taiwan | NT$1.42 Billion |
|
Ansell Ltd
AU:ANN
|
Australia | AU$3.33 Billion |
ResMed Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.01 | 3.41 | 1.73 |
| Quick Ratio | 2.33 | 2.49 | 1.23 |
| Cash Ratio | 0.00 | 0.99 | 0.32 |
| Working Capital | $2.71 Billion | $2.27 Billion | $662.99 Million |
ResMed Inc - Advanced Valuation Insights
This section examines the relationship between ResMed Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 4.62 |
| Latest Market Cap to Assets Ratio | 3.53 |
| Asset Growth Rate (YoY) | 18.9% |
| Total Assets | $8.17 Billion |
| Market Capitalization | $28.83 Billion USD |
Valuation Analysis
Premium Asset Valuation: The market values ResMed Inc's assets at a significant premium (3.53x), suggesting investors see substantial growth potential or unique competitive advantages.
Rapid Asset Growth: ResMed Inc's assets grew by 18.9% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for ResMed Inc (1993–2025)
The table below shows the annual total assets of ResMed Inc from 1993 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-06-30 | $8.17 Billion | +18.95% |
| 2024-06-30 | $6.87 Billion | +1.79% |
| 2023-06-30 | $6.75 Billion | +32.49% |
| 2022-06-30 | $5.10 Billion | +7.78% |
| 2021-06-30 | $4.73 Billion | +3.07% |
| 2020-06-30 | $4.59 Billion | +11.68% |
| 2019-06-30 | $4.11 Billion | +34.07% |
| 2018-06-30 | $3.06 Billion | -11.66% |
| 2017-06-30 | $3.47 Billion | +6.43% |
| 2016-06-30 | $3.26 Billion | +49.20% |
| 2015-06-30 | $2.18 Billion | -7.48% |
| 2014-06-30 | $2.36 Billion | +6.80% |
| 2013-06-30 | $2.21 Billion | +3.41% |
| 2012-06-30 | $2.14 Billion | +3.33% |
| 2011-06-30 | $2.07 Billion | +27.21% |
| 2010-06-30 | $1.63 Billion | +7.85% |
| 2009-06-30 | $1.51 Billion | +7.25% |
| 2008-06-30 | $1.41 Billion | +12.30% |
| 2007-06-30 | $1.25 Billion | +24.31% |
| 2006-06-30 | $1.01 Billion | +30.11% |
| 2005-06-30 | $774.15 Million | +40.97% |
| 2004-06-30 | $549.15 Million | +19.49% |
| 2003-06-30 | $459.60 Million | +22.17% |
| 2002-06-30 | $376.19 Million | +30.58% |
| 2001-06-30 | $288.09 Million | +149.23% |
| 2000-06-30 | $115.59 Million | +28.58% |
| 1999-06-30 | $89.90 Million | +39.16% |
| 1998-06-30 | $64.60 Million | +17.67% |
| 1997-06-30 | $54.90 Million | +16.07% |
| 1996-06-30 | $47.30 Million | +33.99% |
| 1995-06-30 | $35.30 Million | +267.71% |
| 1994-06-30 | $9.60 Million | +84.62% |
| 1993-06-30 | $5.20 Million | -- |
About ResMed Inc
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally. The company operates in two segments, Sleep and Breathing Health, and Residential Care Software. It offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, h… Read more